Society for Neuroscience - Search

Skip Navigation

  • join logo Join
  • give logo Give
  • advocate logo Advocate
  • publish logo Publish
  • Icon with thought bubbles Learn
Shop Sign In
SfN Logo 2025
  • Membership
    • Learn About Membership
      • Individual Member Benefits
      • Institutional Program Member Benefits
      • Sustaining Associate Member Benefits
      • Get Involved at SfN
    • Become a Member
      • Sponsorship Information for New Members
      • Membership Categories & Fees
      • Membership Fees for Developing Countries
      • Renew Individual Membership
    • Member Resources
      • Automatic Renewals
      • Frequently Asked Questions
      • Individual Member Directory
      • Member Obituaries and Memorial Donations
    • Learn About Local Chapters
      • Start or Reactivate a Chapter
      • Resources for Chapters
      • Submit Annual Report
      • Chapter Directory
      • Frequently Asked Questions
  • Meetings
    • Meetings Overview
    • Neuroscience 2025
      • Call for Abstracts
      • Sessions and Events
      • Registration
      • Housing and Travel
      • Exhibits
      • Dates and Deadlines
      • Advertising and Sponsorship
      • FAQs
    • Global Events
      • SfN Virtual Events
    • Past and Future Annual Meetings
      • Neuroscience 2024
      • Neuroscience 2023
      • Search Past Annual Meeting Abstracts
      • Attendance Statistics
    • Meeting Policies and Guidelines
      • Code of Conduct at SfN Events
      • Guidelines for Participating in SfN Events
      • Photography & Recording Policy
      • Presenter Guidelines and Policies for SfN Events
    • Meeting Awards
      • Trainee Professional Development Award
      • International Travel Awards
      • FENS Member Awards to SfN Annual Meeting
      • IBRO Member Awards to SfN Annual Meeting
      • JNS Member Awards to SfN Annual Meeting
  • Careers
    • Careers Overview
    • Institutional Program (IP) Directory
    • NeuroJobs Career Center
      • Job Seekers
      • Employers
    • 2025 Graduate School Fair
    • Career Tools and Resources
      • Neuronline
      • Neurobiology of Disease Workshop
      • Responsible Conduct of Research Short Courses
      • Global Funding Sources
    • Higher Education and Training
      • Core Competencies
      • Neuroscience Training Program Survey
    • Awards
      • Outstanding Career and Research Achievements
      • Early Career
  • Initiatives
    • Initiatives Overview
    • Awards
      • 2024 Award Recipients
      • Awards and Prizes FAQ
      • Trainee Professional Development Award
    • Neuroscience Scholars Program
    • Neuronline
      • Attend
      • Read
      • Watch
      • Listen
      • Collections
    • Resources to Stay Connected
      • SfN Zoom Backgrounds
    • Diversity Initiatives
    • Women and Neuroscience
      • Increasing Women in Neuroscience (IWiN) Courses & Toolkit
      • Celebration of Women in Neuroscience Event
      • Awards
    • Animals in Research
      • Support for Members and Institutions
      • Tools and Resources
      • Resources for Medical Students
    • Public Education Programs
      • Resources for Educators
      • Brain Awareness Video Contest
      • Life of a Neuron Exhibit
  • Advocacy
    • Advocacy Overview
    • Advocacy Response
    • Advocacy Network
      • The NeuroAdvocate Challenge
      • Advocacy Action Center
      • Advocacy Best Practices
      • Advocacy Network News
      • Advocacy Training Seminars
    • US Advocacy Programs
      • Capitol Hill Day
      • Connect with Policymakers
      • Early Career Policy Ambassadors
      • Partner with a Local Chapter
      • Engage the Media
    • Global Advocacy Programs
      • Global Neuroscience Initiatives
      • Global Funding
      • North American Programs
    • Science Funding
      • Advocacy Videos
      • Advocacy Resources
      • US Neuroscience Initiatives
      • Funding Priorities and Processes
    • Policy Positions
      • Statements and Testimony
      • Sign-On Letters
  • Outreach
    • Outreach Overview
    • BrainFacts.org
    • Find a Neuroscientist
    • Brain Awareness Campaign
      • Webinar: The ABC's of BAW
      • How to Get Involved
    • Awards
      • Award for Education in Neuroscience
      • Next Generation Award
      • Chapter of the Year Award
      • Science Educator Award
  • Publications
    • Publications Overview
    • SfN News
    • JNeurosci
    • eNeuro
    • SfN Nexus
    • Neuroscience Quarterly
    • Annual Report
    • History of Neuroscience Autobiographical Chapters
  • About
    • About Overview
    • Mission and Strategic Plan
    • What We Do
      • Annual Report
      • Bylaws
      • Resolutions to the Bylaws
      • Environmental Commitment
      • Strategic Partners
      • History of SfN
    • SfN 50th Anniversary Celebration
    • NIH Public Health Service-Supported Funding Financial Conflict of Interest Policy
    • Volunteer
      • SfN Council
      • SfN Presidents
      • Committees
      • Elections
      • Call for Nominations
    • Professional Conduct
      • SfN Ethics Policy
      • Guidelines for Responsible Conduct Regarding Scientific Communication
      • Code of Conduct at SfN Events
      • Commitment to Scientific Integrity
      • Neuronline Digital Learning Community Guidelines
    • History of Neuroscience
      • Autobiographical Chapters
      • Autobiographical Videos of Prominent Neuroscientists
      • Classic Papers
      • Neuroscience History Resources
      • Robert Doty's Chapter on Neuroscience
    • Careers and Staff
      • Staff List
  1. Search

Filter

  • (2)
  • (1)
  • (3)
  • (6)
  • (8)
  • (1)
  • (574)
  • (3)
  • (2)
  • (8)
Filter
61 - 70 of 890 results
  • Abstract
    EFFECT OF Δ9-TETRAHYDROCANNABINOL (Δ9-THC) ON THE SINGLE-UNIT ACTIVITY OF SEROTONERGIC DORSAL RAPHE NEURONS IN FREELY MOVING CATS.
    Brain serotonin has been implicated in the action of many psychoactive drugs. One agent of particular social and medical interest is Δ9-THC, the major active constituent in marijuana. Although a number of studies have characterized the effect of Δ9-THC on various neurochemical indices of serotonergic function, none has directly examined the effect of this compound on the electrophysiological activity of serotonergic neurons. To determine whether Δ9-THC alters serotonergic neuronal activity, we monitored the firing rate of serotonergic dorsal raphe neurons in behaving animals acutely treated with this agent. Serotonergic neurons were identified and recorded as described previously (Fornal et al., 2001). Systemic administration of Δ9-THC (5 mg/kg, i.p.) produced clear signs of sedation and impaired motor function, which are established characteristics of THC's action. These behavioral effects were evident within 15-30 min after injection and persisted for several hours. During periods when the cats were clea...
    Nov 6, 2002
  • Abstract
    Cannabidiol enhances acetylcholine levels from basal forebrain in rats
    Cannabis sativa is a plant that contains more than 500 components, of which the most studied are Δ9-tetrahydrocannabinol (Δ9-THC) and cannabidiol (CBD). Several studies have indicated that CBD displays neurobiological effects, including wake promotion. ...
    Nov 5, 2018
  • Abstract
    Anticonvulsant and neuroprotective effects of cannabidiol in immature rats
    Appropriate antiepileptic drugs (AEDs) for specific age groups with epilepsy are presently unavailable due to poor understanding of how early-life seizures affect the brain at critical stages in development. Cannabidiol (CBD), the major non-psychoactive...
    Nov 15, 2017
  • Abstract
    Delta-9-Tetrahydrocannabinol vapor inhalation attenuates oxycodone self-administration
    Prescription opioid abuse is a significant global problem, thus the use of non-opioid drugs has been investigated for the treatment of pain and the reduction of adverse effects such as abuse or overdose. The interaction between cannabinoids and opioids ...
    Nov 11, 2017
  • Differential Effects of Presynaptic versus Postsynaptic Adenosine A2A Receptor Blockade on Δ9-Tetrahydrocannabinol (THC) Self-Administration in Squirrel Monkeys | Journal of Neuroscience
    Different doses of an adenosine A2A receptor antagonist MSX-3 [3,7-dihydro-8-[(1E)-2-(3-ethoxyphenyl)ethenyl]-7 methyl-3-[3-(phosphooxy)propyl-1-(2 propynil)-1H-purine-2,6-dione] were found previously to either decrease or increase self-administration of cannabinoids delta-9-tetrahydrocannabinol (THC) or anandamide in squirrel monkeys. It was hypothesized that the decrease observed with a relatively low dose of MSX-3 was related to blockade of striatal presynaptic A2A receptors that modulate glutamatergic neurotransmission, whereas the increase observed with a higher dose was related to blockade of postsynaptic A2A receptors localized in striatopallidal neurons. This hypothesis was confirmed in the present study by testing the effects of the preferential presynaptic and postsynaptic A2A receptor antagonists SCH-442416 \[2-(2-furanyl)-7-[3-(4-methoxyphenyl)propyl]-7H-pyrazolo[4,3-e\]\[1,2,4\]triazolo[1,5-c]pyrimidin-5-amine] and KW-6002 [(E)-1, 3-diethyl-8-(3,4-dimethoxystyryl)-7-methyl-3,7-dihydro-1H-purin...
    May 7, 2014 Zuzana Justinová
  • Abstract
    Differential effects of cannabidiol and a novel cannabidiol analog on oxycodone place preference and analgesia in mice; an opioid abuse deterrent with analgesic properties
    This study sought to compare cannabidiol to a cannabidiol analog, CBD-VHS, and its ability to attenuate oxycodone reward without affecting its analgesic effects. In Experiment 1) Mice were enrolled in the conditioned place preference paradigm and receiv...
    Oct 23, 2019
  • Effects of Cannabidiol, Hypothermia, and Their Combination in Newborn Rats with Hypoxic-Ischemic Encephalopathy | eNeuro
    Therapeutic hypothermia is well established as a standard treatment for infants with hypoxic-ischemic (HI) encephalopathy but it is only partially effective. The potential for combination treatments to augment hypothermic neuroprotection has major relevance. Our aim was to assess the effects of treating newborn rats following HI injury with cannabidiol (CBD) at 0.1 or 1 mg/kg, i.p., in normothermic (37.5°C) and hypothermic (32.0°C) conditions, from 7 d of age (neonatal phase) to 37 d of age (juvenile phase). Placebo or CBD was administered at 0.5, 24, and 48 h after HI injury. Two sensorimotor (rotarod and cylinder rearing) and two cognitive (novel object recognition and T-maze) tests were conducted 30 d after HI. The extent of brain damage was determined by magnetic resonance imaging, histologic evaluation, magnetic resonance spectroscopy, amplitude-integrated electroencephalography, and Western blotting. At 37 d, the HI insult produced impairments in all neurobehavioral scores (cognitive and sensorimotor...
    May 1, 2023 Francisco J. Alvarez
  • Abstract
    Long-term effects of adolescent THC exposure: role of prenatal environment
    The two-hit hypothesis of adult psychopathology predicts that a combination of prenatal and postnatal environmental insults increases risks for major psychiatric disorders. We generated a mouse model of environment x environment (E x E) interaction base...
    Nov 10, 2021
  • Abstract
    Adolescent THC Persistently Alters Medial Prefrontal Cortex-Dependent Cognition in Rats
    Epidemiological studies suggest a link between early adolescent cannabis use and risk of developing schizophrenia, but whether Δ9-tetrahydrocannabinol (THC) actually precipitates schizophrenia symptoms remains unclear. Moreover, the neurobiological mech...
    Nov 9, 2021
  • Abstract
    Novel synthetic cannabidiol enantiomer modulates delta and beta wavelength EEG activity
    Novel synthetic cannabidiol enantiomer modulates δ and β wavelength EEG activityApril Contreras1, William A. Maio2, Dustin J. Hines1, and Rochelle M. Hines11Interdisciplinary Neuroscience PhD Program, Department of Psychological and Brain Sciences,Unive...
    Nov 9, 2021
  • Previous
  • 5
  • 6
  • 7
  • 8
  • 9
  • Next

Featured

  • Watch: The Inspiration Behind the Neuroscience 2025 Logo
  • Upcoming Webinar: JNeurosci Town Hall
  • Find a Roommate for Neuroscience 2025 in the Roommate Matching Forum
SfN Websites
  • BrainFacts.org logo
  • eNeuro logo
  • JNeurosci logo
  • Neuronline logo
Engage with SfN
  • join Join
  • give Give
  • advocate Advocate
  • publish Publish
Quick Links
  • SfN News
  • For Press
  • Global Events
  • Contact Us
  • Advertise
  • Code of Conduct
  • Jobs at SfN
  • SfN Store
  • Social Media
Follow SfN
  • BlueSky logo
  • Facebook logo
  • Instagram logo
  • LinkedIn logo

  • Threads logo
  • X Logo
  • YouTube logo
SfN logo with "SfN" in a blue box next to Society for Neuroscience in red text and the SfN tag line that reads "Advancing the understanding of the brain and nervous system"
1121 14th Street NW, Suite 1010, Washington, D.C. 20005
(202) 962-4000 | 1-888-985-9246
  • Accessibility Policy
  • Disclaimer
  • Privacy Notice
  • Contact Us

Copyright ©
Society for Neuroscience